Pharmacokinetics and bioavailability of itraconazole oral solution in cats. 2016

Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
National Reference Laboratory of Veterinary Drug Residues (SCAU), College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.

OBJECTIVE The aim of this study was to describe the pharmacokinetics and bioavailability of itraconazole (ITR) oral solution in healthy cats. METHODS The pharmacokinetics of ITR were studied in eight healthy, fasted cats after a single intravenous (IV) and oral (PO) administration at a dose of 5 mg/kg, in a two-period crossover design study. Blood was obtained at predetermined intervals for the determination of ITR concentrations with high-performance liquid chromatography. Pharmacokinetic characterisation was performed by a non-compartmental method using WinNonlin 5.2.1. RESULTS After IV administration, the major pharmacokinetic parameters were as follows (mean ± SD): terminal elimination half-life (T1/2λz ) 15.8 ± 1.88 h; area under the curve from time zero to infinity (AUC0-∞ ) 13.9 ± 3.17 h·μg/ml; total body clearance 0.37 ± 0.08 l/h/kg; apparent volume of distribution 8.51 ± 1.92 l/kg; mean residence time 20.6 ± 3.95 h. After PO administration, the principal pharmacokinetic parameters were as follows (mean ± SD): T1/2λz 15.6 ± 3.20 h; AUC0-∞ 7.94 ± 2.83 h·μg/ml; peak concentration 0.70 ± 0.14 μg/ml; time of peak 1.43 ± 0.53 h. The absolute bioavailability of ITR oral solution after oral administration was 52.1 ± 11.6%. CONCLUSIONS The disposition of ITR oral solution in cats is characterised by a long terminal half-life, a short peak time and moderate bioavailability.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D002371 Cat Diseases Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used. Feline Diseases,Cat Disease,Disease, Cat,Disease, Feline,Diseases, Cat,Diseases, Feline,Feline Disease
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D017964 Itraconazole A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis. Orungal,R-51211,Sporanox,R 51211,R51211
D019540 Area Under Curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992) AUC,Area Under Curves,Curve, Area Under,Curves, Area Under,Under Curve, Area,Under Curves, Area
D019999 Pharmaceutical Solutions Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products. Pharmaceutic Solutions,Solutions, Pharmaceutical,Solutions, Pharmaceutic

Related Publications

Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
February 1997, AIDS patient care and STDs,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
February 1995, Journal of veterinary pharmacology and therapeutics,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
January 2013, Clinica chimica acta; international journal of clinical chemistry,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
July 2009, International journal of hematology,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
June 2001, Journal of clinical pharmacy and therapeutics,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
July 2017, Journal of veterinary internal medicine,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
February 1998, Antimicrobial agents and chemotherapy,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
December 2001, Journal of clinical pharmacology,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
May 2001, Antimicrobial agents and chemotherapy,
Chaoping Liang, and Qi Shan, and Jialian Zhong, and Wei Li, and Xiufeng Zhang, and Jing Wang, and Changfu Cao, and Zhenling Zeng
January 1998, Pharmacotherapy,
Copied contents to your clipboard!